| scholarly article | Q13442814 |
| P50 | author | Myron I. Cybulsky | Q50631476 |
| P2093 | author name string | M A Gimbrone | |
| N Kume | |||
| P2860 | cites work | Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins | Q24292943 |
| Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis | Q24301047 | ||
| Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation | Q70580552 | ||
| Effects of amphiphiles on erythrocytes, coronary arteries, and perfused hearts | Q71500536 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families | Q28114775 | ||
| Selectins: a family of adhesion receptors | Q28279148 | ||
| Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
| The molecular heterogeneity of protein kinase C and its implications for cellular regulation | Q29619947 | ||
| Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis | Q33567912 | ||
| Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells | Q33667974 | ||
| Low density lipoprotein undergoes oxidative modification in vivo | Q33838672 | ||
| Monocyte chemoattractant protein-1 in human atheromatous plaques | Q34203056 | ||
| Minimally modified low density lipoprotein stimulates monocyte endothelial interactions | Q34248823 | ||
| Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia | Q34340579 | ||
| Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros | Q34360883 | ||
| Alternative splicing of human VCAM-1 in activated vascular endothelium | Q35830499 | ||
| Expression of intercellular adhesion molecule-1 in atherosclerotic plaques | Q35830615 | ||
| Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats | Q35885920 | ||
| Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism | Q36350921 | ||
| Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions | Q37532544 | ||
| Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription | Q37557587 | ||
| Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. | Q37630364 | ||
| The pathogenesis of atherosclerosis: atherogenesis and inflammation | Q39631836 | ||
| The pathogenesis of atherosclerosis--an update | Q39726917 | ||
| Role of secretory phospholipases A2 in the pathobiology of disease | Q39744076 | ||
| Role of oxidized low density lipoprotein in atherogenesis | Q40343074 | ||
| Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages | Q41661978 | ||
| An inducible endothelial cell surface glycoprotein mediates melanoma adhesion | Q41758433 | ||
| Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis | Q44121998 | ||
| Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation. | Q44159810 | ||
| Endothelial-leukocyte adhesion molecule-1-dependent and leukocyte (CD11/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium | Q45865181 | ||
| Analysis of the monocyte chemotactic response to lysophosphatidylcholine: role of lysophospholipase C. | Q46132358 | ||
| Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. | Q46426029 | ||
| Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein | Q46616886 | ||
| ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. | Q48328947 | ||
| Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins | Q59060592 | ||
| Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 | Q67681256 | ||
| Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation. Studies with phorbol myristate acetate and staurosporine | Q67687134 | ||
| Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1 | Q67689512 | ||
| Receptors for modified low-density lipoproteins on human endothelial cells: different recognition for acetylated low-density lipoprotein and oxidized low-density lipoprotein | Q68197655 | ||
| Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis | Q68433741 | ||
| Beta-very low density lipoprotein pretreatment of endothelial monolayers increases monocyte adhesion | Q69557286 | ||
| Lysophosphatidylcholine metabolism to 1,2-diacylglycerol in lymphoblasts: involvement of a phosphatidylcholine-hydrolyzing phospholipase C | Q69647813 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 1138-1144 | |
| P577 | publication date | 1992-09-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells | |
| P478 | volume | 90 |
| Q41292549 | A global view on the role of monocytes and platelets in atherogenesis |
| Q41225298 | A monoclonal antibody, 3/22, to rabbit CD11c which induces homotypic T cell aggregation: evidence that ICAM-1 is a ligand for CD11c/CD18. |
| Q28293294 | A novel lysophospholipid- and pH-sensitive receptor, GPR4, in brain endothelial cells regulates monocyte transmigration |
| Q44079756 | A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures |
| Q74445926 | A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit |
| Q22009046 | A specific human lysophospholipase: cDNA cloning, tissue distribution and kinetic characterization |
| Q77340592 | Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice |
| Q35539166 | Accelerated vascular disease in systemic lupus erythematosus: role of macrophage |
| Q41121082 | Activation of ICAM-1 promoter by lysophosphatidylcholine: possible involvement of protein tyrosine kinases |
| Q34116412 | Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production |
| Q44228296 | Alpha-tocopherol prevents apoptosis of vascular endothelial cells via a mechanism exceeding that of mere antioxidation |
| Q64057248 | An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases |
| Q44149378 | An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma |
| Q37142814 | Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. |
| Q34099697 | Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor |
| Q41154173 | Antioxidants, atherosclerosis and thrombosis. |
| Q37368639 | Aortic endothelial cells regulate proliferation of human monocytes in vitro via a mechanism synergistic with macrophage colony-stimulating factor. Convergence at the cyclin E/p27(Kip1) regulatory checkpoint |
| Q33853451 | Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endothelium |
| Q36993382 | Association of age-related changes in circulating intermediary lipid metabolites, inflammatory and oxidative stress markers, and arterial stiffness in middle-aged men. |
| Q77124466 | Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis |
| Q33602983 | Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke |
| Q57616453 | Association of lipoprotein-associated phospholipase A2 and endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q41211970 | Atheroma: more than mush |
| Q78023007 | Atherosclerosis and inflammation mononuclear cell recruitment and adhesion molecules with reference to the implication of ICAM-1/LFA-1 pathway in atherogenesis |
| Q37033339 | Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association |
| Q40418236 | Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action |
| Q26822655 | Atherosclerosis: process, indicators, risk factors and new hopes |
| Q35860029 | Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches |
| Q34006292 | Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities |
| Q24306312 | CAP37, a neutrophil-derived inflammatory mediator, augments leukocyte adhesion to endothelial monolayers |
| Q37598024 | Cardiovascular determinants of life span. |
| Q37165251 | Carotid plaque is a new risk factor for peripheral vestibular disorder: a retrospective cohort study |
| Q40900648 | Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease |
| Q33686005 | Cellular adhesion molecules and atherogenesis |
| Q58246532 | Chemokines and atherosclerosis |
| Q79264651 | Circulating ICAM-1, VCAM-1, E-selectin, P-selectin, and TNFalphaRII in patients with coronary artery disease |
| Q60746676 | Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines |
| Q48139850 | DI/LC-MS/MS-Based Metabolic Profiling for Identification of Early Predictive Serum Biomarkers of Metritis in Transition Dairy Cows |
| Q55507453 | DNA scission and LDL cholesterol oxidation inhibition and antioxidant activities of Bael (Aegle marmelos) flower extracts. |
| Q37650398 | Darapladib |
| Q54472600 | Dextromethorphan attenuates LPS-induced adhesion molecule expression in human endothelial cells. |
| Q40771130 | Dietary hematein ameliorates fatty streak lesions in the rabbit by the possible mechanism of reducing VCAM-1 and MCP-1 expression |
| Q42908132 | Dietary rice protein isolate attenuates atherosclerosis in apoE-deficient mice by upregulating antioxidant enzymes |
| Q28345443 | Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice |
| Q35877997 | Dual role of oxidized LDL on the NF-kappaB signaling pathway. |
| Q36897185 | Effect of quercetin and its metabolite on caveolin-1 expression induced by oxidized LDL and lysophosphatidylcholine in endothelial cells |
| Q38459247 | Effects of atorvastatin treatment on the oxidatively modified low density lipoprotein in hyperlipidemic patients |
| Q73943173 | Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women |
| Q30841151 | Effects of lysophospholipids on the generation of reactive oxygen species by fMLP- and PMA-stimulated human neutrophils |
| Q33649831 | Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions |
| Q32063018 | Effects of simvastatin treatment on sICAM-1 and sE-selectin levels in hypercholesterolemic subjects. |
| Q36602763 | Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis |
| Q35833913 | Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts. |
| Q64904723 | Endothelial cells regulate the proliferation of monocytes in vitro. |
| Q41349596 | Endothelial function. General considerations |
| Q34553611 | Endothelial lipase (EL) and EL-generated lysophosphatidylcholines promote IL-8 expression in endothelial cells |
| Q53633905 | Estradiol Inhibits Cytokine-Induced Expression of VCAM-1 and ICAM-1 in Cultured Human Endothelial Cells Via AMPK/PPARα Activation. |
| Q34557438 | Estrogen replacement therapy and cardioprotection: mechanisms and controversies |
| Q73807338 | Evaluation of potential tracer ability of (99m)Tc-labeled acetylated LDL for scintigraphy of LDL-scavenger receptor sites of macrophageal origin |
| Q34040134 | Exchange of monooleoylphosphatidylcholine with single egg phosphatidylcholine vesicle membranes |
| Q73111093 | Expression of vascular cell adhesion molecule-1 (VCAM-1) in the aortae of hypercholesterolemic rabbits with high (HAR) and low (LAR) atherosclerotic response |
| Q37387430 | Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction |
| Q28290435 | Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene |
| Q47693085 | Glucose-modified low density lipoprotein enhances human monocyte chemotaxis |
| Q43600403 | Group X secretory phospholipase A(2) induces potent productions of various lipid mediators in mouse peritoneal macrophages |
| Q34554267 | HDL and arteriosclerosis: beyond reverse cholesterol transport |
| Q71799260 | High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules |
| Q33596730 | High-density lipoprotein: multipotent effects on cells of the vasculature. |
| Q43912991 | Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells |
| Q39802780 | Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice |
| Q40393787 | Hyperlipidemic endothelial injury and angiogenesis |
| Q74445963 | Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells |
| Q24312195 | Identification and characterization of a novel monocyte/macrophage differentiation-dependent gene that is responsive to lipopolysaccharide, ceramide, and lysophosphatidylcholine |
| Q30967113 | Identification of a Moraxella catarrhalis outer membrane protein exhibiting both adhesin and lipolytic activities |
| Q28594789 | Identification of an insulin-regulated lysophospholipase with homology to neuropathy target esterase |
| Q37341184 | Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear str |
| Q28216302 | Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor |
| Q40696369 | Immune mechanisms in atherogenesis |
| Q35753555 | Immunomodulation and vaccination for atherosclerosis |
| Q35956933 | Impact of 4-epi-oxytetracycline on the gut microbiota and blood metabolomics of Wistar rats |
| Q54582097 | Increased monocytic adhesion by senescence in human umbilical vein endothelial cells. |
| Q35561902 | Induction of Atherosclerosis by Human Chylomicron Remnants: A Hypothesis |
| Q35763802 | Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine |
| Q34027327 | Inflammation and lipid-lowering treatment |
| Q35124954 | Inflammatory Reactions in the Pathogenesis of Atherosclerosis |
| Q28178880 | Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells |
| Q44474827 | Inhibition of Akt phosphorylation by thrombin, histamine and lysophosphatidylcholine in endothelial cells. Differential role of protein kinase C. |
| Q74341101 | Inhibition of endothelium-dependent arterial relaxation by oxidized phosphatidylcholine |
| Q34016317 | Inhibition of lipoprotein-associated phospholipase A2 ameliorates inflammation and decreases atherosclerotic plaque formation in ApoE-deficient mice |
| Q35906619 | Innate Immune Proteins C1q and Mannan-Binding Lectin Enhance Clearance of Atherogenic Lipoproteins by Human Monocytes and Macrophages |
| Q57741422 | Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia |
| Q78125646 | Intracellular generation of MDA-LYS epitope in foam cells |
| Q73256291 | Isolation, Characterization, and Functional Assessment of Oxidatively Modified Subfractions of Circulating Low-Density Lipoproteins |
| Q73450439 | LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells |
| Q40753493 | Lectin-like oxidized LDL receptor-1 (LOX-1) supports adhesion of mononuclear leukocytes and a monocyte-like cell line THP-1 cells under static and flow conditions |
| Q77584938 | Leukocyte-endothelium adhesion molecules in atherosclerosis |
| Q77742461 | Lipid peroxidation of isolated chylomicrons and oxidative status in plasma after intake of highly purified eicosapentaenoic or docosahexaenoic acids |
| Q30433384 | Lipid retention in the arterial wall of two mouse strains with different atherosclerosis susceptibility |
| Q41026278 | Lipidomic analysis of human plasma reveals ether-linked lipids that are elevated in morbidly obese humans compared to lean |
| Q26860086 | Lipids and the endothelium: bidirectional interactions |
| Q36517373 | Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study |
| Q34464823 | Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients. |
| Q47573615 | Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease: Findings from The Atherosclerosis Risk in Communities study (ARIC). |
| Q26777871 | Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications |
| Q42992999 | Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor |
| Q36187055 | Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic target |
| Q35765135 | Lipoproteins modulate expression of the macrophage scavenger receptor |
| Q34796252 | Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice. |
| Q37698833 | Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE-/- mice. |
| Q44223651 | Low density lipoprotein oxidized in xanthoma tissue induces the formation and infiltration of foam cells |
| Q80968491 | Low-calorie cranberry juice supplementation reduces plasma oxidized LDL and cell adhesion molecule concentrations in men |
| Q33664272 | Lp-PLA2 Inhibition-The Atherosclerosis Panacea? |
| Q38368000 | LysoPC and PAF Trigger Arachidonic Acid Release by Divergent Signaling Mechanisms in Monocytes |
| Q60498985 | Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism |
| Q47922358 | Lysophosphatidylcholine Acts as an Anti-hemostatic Molecule in the Saliva of the Blood-sucking Bug Rhodnius prolixus |
| Q93052009 | Lysophosphatidylcholine Induces NLRP3 Inflammasome-Mediated Foam Cell Formation and Pyroptosis in Human Monocytes and Endothelial Cells |
| Q41690115 | Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCgamma-1 and tyrosine kinase-Ras pathways |
| Q77366607 | Lysophosphatidylcholine activates mitogen-activated protein kinases by a tyrosine kinase-dependent pathway in bovine aortic endothelial cells |
| Q43749566 | Lysophosphatidylcholine activates transcription factor NF-kappaB and AP-1 in AR42J cells |
| Q46889699 | Lysophosphatidylcholine as a ligand for immunoregulation |
| Q39878177 | Lysophosphatidylcholine exhibits selective cytotoxicity, accompanied by ROS formation, in RAW 264.7 macrophages |
| Q28295925 | Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4 |
| Q38329462 | Lysophosphatidylcholine increases endothelial permeability: role of PKCalpha and RhoA cross talk |
| Q32062986 | Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells |
| Q43913008 | Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism |
| Q74106117 | Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL |
| Q39900527 | Lysophosphatidylcholine induces glial cell activation: role of rho kinase |
| Q80079006 | Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells |
| Q47987190 | Lysophosphatidylcholine induces the production of IL-1beta by human monocytes |
| Q43901462 | Lysophosphatidylcholine inhibits the expression of prostacyclin stimulating factor in cultured vascular smooth muscle cells |
| Q38320971 | Lysophosphatidylcholine phosphorylates CREB and activates the jun2TRE site of c-jun promoter in vascular endothelial cells |
| Q36990649 | Lysophosphatidylcholine plays critical role in allergic airway disease manifestation |
| Q53497838 | Lysophosphatidylcholine promotes SREBP-2 activation via rapid cholesterol efflux and SREBP-2-independent cytokine release in human endothelial cells. |
| Q38758160 | Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of gram-negative and gram-positive shock |
| Q71061251 | Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells |
| Q34128848 | Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells |
| Q44922467 | Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells |
| Q41008665 | Lysophosphatidylcholine upregulates CD40 ligand expression in newly activated human CD4+ T cells. |
| Q37558661 | Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes |
| Q46611141 | Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces the change of calcium mobilization via TRPC ion channels in cultured human corporal smooth muscle cells. |
| Q72566031 | Lysophosphatidylcholine: a chemoattractant to human T lymphocytes |
| Q44378760 | Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium |
| Q47191829 | Lysophospholipid-Related Diseases and PPARγ Signaling Pathway. |
| Q38643186 | Lysophospholipids and their G protein-coupled receptors in atherosclerosis |
| Q33681195 | Mammalian lysophospholipases. |
| Q34107311 | Mechanism of action of niacin on lipoprotein metabolism |
| Q74702825 | Metabolism of oxidized and chemically modified low density lipoproteins in rainbow trout--clearance via scavenger receptors |
| Q92577737 | Metabolomics reveals a link between homocysteine and lipid metabolism and leukocyte telomere length: the ENGAGE consortium |
| Q34114272 | Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate |
| Q37151049 | Mitochondria and AMP-activated protein kinase-dependent mechanism of efferocytosis |
| Q34524163 | Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation |
| Q43606363 | Mitogenic effect of lipoproteins on human vascular smooth muscle cells: the impact of hydrolysis by gr II A phospholipase A(2). |
| Q35553734 | Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells |
| Q41715190 | Molecular biology of atherosclerosis |
| Q36742194 | Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium |
| Q73389643 | Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cells |
| Q41039459 | Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands |
| Q36924678 | Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis |
| Q73565070 | Native and gamma radiolysis-oxidized lipoprotein(a) increase the adhesiveness of rabbit aortic endothelium |
| Q41093059 | Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. |
| Q39799854 | Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells |
| Q47148282 | New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis. |
| Q50952139 | New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart diseas |
| Q34674199 | New scavenger receptors and their functions in atherogenesis |
| Q36628207 | Nitric oxide function in atherosclerosis |
| Q37386373 | Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells |
| Q62029329 | Normal human IgG prevents endothelial cell activation induced by TNFalpha and oxidized low-density lipoprotein atherogenic stimuli |
| Q73442734 | Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation |
| Q33995853 | Novel lysophospholipase A secreted by Legionella pneumophila. |
| Q39499283 | Novel phospholipase A activity secreted by Legionella species |
| Q36365606 | On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety |
| Q70937445 | Oxidation of low density lipoproteins greatly enhances their association with lipoprotein lipase anchored to endothelial cell matrix |
| Q34273046 | Oxidative stress in cardiovascular disease |
| Q41063669 | Oxidatively modified LDL and atherosclerosis: an evolving plausible scenario |
| Q34172169 | Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes |
| Q63358400 | Oxidised LDL (OxLDL) induces production of platelet derived growth factor AA (PDGF AA) from aortic smooth muscle cells |
| Q37387741 | Oxidized LDL activates fas-mediated endothelial cell apoptosis |
| Q33788659 | Oxidized LDL and expression of monocyte adhesion molecules |
| Q73348982 | Oxidized LDL inhibits vascular endothelial cell morphogenesis in culture |
| Q43850686 | Oxidized low density lipoprotein inhibits prostacyclin generation by rat aorta in vitro: a key role of lysolecithin |
| Q77601534 | Oxidized phospholipids as a new landmark in atherosclerosis |
| Q37420076 | Oxidized phospholipids in control of inflammation and endothelial barrier |
| Q38886902 | PM2.5-induced oxidative stress increases adhesion molecules expression in human endothelial cells through the ERK/AKT/NF-κB-dependent pathway |
| Q39900686 | Phosphatidylcholine hydroperoxide-induced THP-1 cell adhesion to intracellular adhesion molecule-1. |
| Q41056267 | Phosphatidylinositol 3-kinase is involved in the induction of macrophage growth by oxidized low density lipoprotein |
| Q44799785 | Physiological mechanisms of lysophosphatidylcholine-induced de-ramification of murine microglia |
| Q39923102 | Poloxamer 407 increases soluble adhesion molecules, ICAM-1, VCAM-1 and E-selectin, in C57BL/6 mice |
| Q35609302 | Poloxamer 407-induced atherosclerosis in mice appears to be due to lipid derangements and not due to its direct effects on endothelial cells and macrophages |
| Q36913018 | Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in? |
| Q73020416 | Proliferation of smooth muscle cells in acute allograft vascular rejection |
| Q43975784 | Prolonged, low dose alpha-tocopherol therapy counteracts intercellular cell adhesion molecule-1 activation |
| Q42448839 | Protective effects of EPA and deleterious effects of DHA on eNOS activity in Ea hy 926 cultured with lysophosphatidylcholine |
| Q24309062 | Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins |
| Q37711748 | QGQS Granule in SHR Serum Metabonomics Study Based on Tools of UPLC-Q-TOF and Renin-Angiotensin-Aldosterone System Form Protein Profilin-1. |
| Q34085160 | RETRACTED: Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. |
| Q77696707 | Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain |
| Q42738483 | Regulation of eosinophil adhesion by lysophosphatidylcholine via a non-store-operated Ca2+ channel |
| Q43640283 | Regulation of tyrosine phosphorylation of PYK2 in vascular endothelial cells by lysophosphatidylcholine |
| Q41879005 | Respiratory infection in lipid-fed rabbits enhances sudanophilia and the expression of VCAM-1. |
| Q41647634 | Role of endothelial dysfunction in coronary artery disease and implications for therapy |
| Q43757294 | Role of lysophosphatidylcholine in the desensitization of beta-adrenergic receptors by Ca(2+) sensitization in tracheal smooth muscle |
| Q37356330 | Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein |
| Q41067946 | Role of membrane-anchored heparin-binding epidermal growth factor-like growth factor and CD9 on macrophages |
| Q36969006 | Role of oxidative stress in adaptive responses in special reference to atherogenesis |
| Q51323656 | Role of the lipid-regulated NF-κB/IL-6/STAT3 axis in alpha-naphthyl isothiocyanate-induced liver injury. |
| Q41680651 | Role of vascular nitric oxide in physiological and pathological conditions |
| Q37858911 | Secreted phospholipase A2, lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics |
| Q41743134 | Selective activation of endothelial cells by the antioxidant pyrrolidine dithiocarbamate: involvement of C-jun N-terminal kinase and AP-1 activation |
| Q45114691 | Severity dependent up-regulations of LOX-1 and MCP-1 in early sclerotic changes of common carotid arteries in spontaneously hypertensive rats |
| Q35111638 | Short-term fenofibrate treatment reduces elevated plasma Lp-PLA2 mass and sVCAM-1 levels in a subcohort of hypertriglyceridemic GOLDN participants |
| Q33399462 | Silent myocardial ischemia is associated with altered plasma phospholipids |
| Q58831743 | Simultaneous determination of lysophospholipids by high-performance liquid chromatography with fluorescence detection |
| Q33915296 | Spontaneous transfer of monoacyl amphiphiles between lipid and protein surfaces |
| Q42159046 | Stimulatory and inhibitory actions of lysophosphatidylcholine, depending on its fatty acid residue, on the phospholipase C/Ca2+ system in HL-60 leukaemia cells |
| Q35730371 | Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils |
| Q42019157 | Synthesis and secretion of the pancreatic-type carboxyl ester lipase by human endothelial cells |
| Q37033345 | Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention |
| Q42116807 | Terminalia bellirica Extract Inhibits Low-Density Lipoprotein Oxidation and Macrophage Inflammatory Response in Vitro. |
| Q34008359 | Testing for endothelial dysfunction |
| Q37362273 | Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. |
| Q35978114 | The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis |
| Q42201820 | The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes |
| Q47739578 | The atherogenic lipoprotein phenotype and vascular endothelial dysfunction |
| Q40802362 | The biology of the artery wall in atherogenesis. |
| Q46703022 | The effect of ciprofibrate on flow-mediated dilation and inflammatory markers in patients with combined hyperlipidemia |
| Q72997317 | The effect of humic acid on the adhesibility of neutrophils |
| Q46138167 | The effect of short-term, high glucose concentration on endothelial cells and leukocytes in a 3D in vitro human vascular tissue model |
| Q40343252 | The effects of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent |
| Q34132213 | The expression of extracellular-superoxide dismutase is increased by lysophosphatidylcholine in human monocytic U937 cells |
| Q40185940 | The influence of lysolipids on the spontaneous curvature and bending elasticity of phospholipid membranes |
| Q33566165 | The inhibition of lipoprotein-associated phospholipase A2 exerts beneficial effects against atherosclerosis in LDLR-deficient mice |
| Q45152910 | The levels of soluble adhesion molecules in diabetic and nondiabetic patients with combined hyperlipoproteinemia and the effect of ciprofibrate therapy |
| Q24629974 | The response-to-retention hypothesis of early atherogenesis |
| Q39238621 | The role of ROS in ionizing radiation-induced VLA-4 mediated adhesion of RAW264.7 cells to VCAM-1 under flow conditions |
| Q40418229 | The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease |
| Q71762941 | The scavenger receptor serves as a route for internalization of lysophosphatidylcholine in oxidized low density lipoprotein-induced macrophage proliferation |
| Q35744631 | The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach |
| Q38450708 | Transcriptional profiling of human smooth muscle cells infected with gingipain and fimbriae mutants of Porphyromonas gingivalis |
| Q42480352 | Transcriptional regulation of endothelial nitric-oxide synthase by an interaction between casein kinase 2 and protein phosphatase 2A. |
| Q42456169 | Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidylcholine |
| Q41780489 | Transient receptor potential canonical 5 channels plays an essential role in hepatic dyslipidemia associated with cholestasis. |
| Q35120360 | Triglycerides and heart disease: still a hypothesis? |
| Q28570578 | Unique repetitive sequence and unexpected regulation of expression of rat endothelial receptor for oxidized low-density lipoprotein (LOX-1) |
| Q35583193 | Up regulation of C3, C4, and soluble intercellular adhesion molecule-1 co-expresses with high sensitivity C reactive protein in familial hypoalphalipoproteinaemia: further evidence of inflammatory activation |
| Q31478590 | Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase gamma /Janus kinase 2/MEK-1-dependent pathway |
| Q28298188 | Upregulation of endothelial adhesion molecules by lysophosphatidylcholine. Involvement of G protein-coupled receptor GPR4 |
| Q36279562 | Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis |
| Q35692035 | Vaccination and atherosclerosis |
| Q40339111 | Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis |
| Q33596955 | Vasospasm, vascular injury, and atherogenesis: a perspective |
| Q33607440 | Why are low-density lipoproteins atherogenic? |
Search more.